Original text
Rate this translation
Your feedback will be used to help improve Google Translate
20 peer-reviewed studies, journals, and research papers — all source-linked.
20 results
Author: Bryant A et al.
Disease: COVID-19 / Viral Infections
Treatment: Ivermectin
Journal: American Journal of Therapeutics
Date: 2021-06-17
Meta-analysis of 24 RCTs: Ivermectin showed large, statistically significant reductions in COVID-19 mortality, hospitalization, and duration. WHO and FDA guidance actively contradicted this evidence. Drug is off-patent and costs under $1/dose.
View Study SourceAuthor: Grant WB et al.
Disease: COVID-19 / Infectious Disease
Treatment: Vitamin D3 (High Dose)
Journal: Nutrients
Date: 2020-07-01
Virtually every severe COVID-19 patient was Vitamin D deficient. Evidence review shows Vitamin D upregulates innate immune antimicrobials, reduces cytokine storm risk, and modulates T-cell response. Governments promoted vaccines but not Vitamin D supplementation.
View Study SourceAuthor: Dogra N et al.
Disease: Cancer
Treatment: Fenbendazole
Journal: Scientific Reports
Date: 2019-01-15
Fenbendazole, an antiparasitic drug, showed complete tumor regression in animal models via microtubule disruption, GLUT transporter inhibition, and p53-mediated apoptosis. Human case series documented full remissions in stage 4 lung cancer.
View Study SourceAuthor: Croteau E et al.
Disease: Alzheimer's Disease
Treatment: Ketogenic / MCT Diet
Journal: Frontiers in Aging Neuroscience
Date: 2018-06-01
Ketone bodies provide alternative fuel for glucose-starved neurons in Alzheimer's brains. MCT oil supplementation documented significant cognitive improvements. Dr. Mary Newport documented dramatic reversal in her husband using coconut oil (MCT) — ignored by mainstream neurology.
View Study SourceAuthor: Lean MEJ et al.
Disease: Type 2 Diabetes
Treatment: Very Low Calorie Diet
Journal: The Lancet
Date: 2018-02-10
46% of patients achieved full T2D remission at 1 year with no medications via calorie restriction. 86% of those who lost 15kg+ achieved remission. Demonstrates T2D is fully reversible through diet — rarely communicated to patients.
View Study SourceAuthor: Konijeti GG et al.
Disease: Crohn's / IBD
Treatment: Autoimmune Protocol (AIP) Diet
Journal: Inflammatory Bowel Diseases
Date: 2017-11-01
78% of IBD patients achieved clinical remission after AIP elimination diet removing gluten, dairy, grains, legumes, nightshades. Endoscopic remission confirmed in 70%. Mechanism: removal of dietary antigens causing leaky gut and molecular mimicry.
View Study SourceAuthor: Budoff MJ et al.
Disease: Cardiovascular Disease
Treatment: Aged Garlic Extract
Journal: Journal of the American College of Cardiology
Date: 2016-10-25
Double-blind RCT: Aged Garlic Extract reduced low-attenuation plaque volume by 4.7% compared to progression in placebo group. Also reduced coronary artery calcium progression. Costs ~$20/month with no adverse events.
View Study SourceAuthor: Bredesen DE
Disease: Alzheimer's Disease
Treatment: ReCODE Protocol (Bredesen)
Journal: Aging
Date: 2014-09-27
9 out of 10 patients with Alzheimer's and MCI showed measurable cognitive reversal using a personalized metabolic protocol targeting 36 factors (diet, sleep, exercise, toxins, hormones, nutrients). No pharmaceutical drugs used.
View Study SourceAuthor: Longo VD, Mattson MP
Disease: Multiple Metabolic Diseases
Treatment: Intermittent Fasting
Journal: Cell Metabolism
Date: 2014-02-04
Fasting triggers autophagy (Nobel Prize 2016 - Ohsumi), reduces insulin resistance, improves mitochondrial function, reduces inflammation, and reverses metabolic syndrome. Pharmaceutical industry cannot patent or profit from fasting.
View Study SourceAuthor: Del Gobbo LC et al.
Disease: Cardiovascular Disease
Treatment: Magnesium Supplementation
Journal: American Journal of Clinical Nutrition
Date: 2013-01-01
Meta-analysis: magnesium deficiency directly causes arrhythmia, hypertension, and arterial calcification. Most modern populations are deficient due to soil depletion. Supplementation costs ~$5/month. Rarely prescribed despite overwhelming mechanistic and epidemiological evidence.
View Study SourceAuthor: Mori K et al.
Disease: Alzheimer's / Cognitive Decline
Treatment: Lion's Mane Mushroom
Journal: Phytotherapy Research
Date: 2009-03-23
Double-blind RCT: Lion's Mane (Hericium erinaceus) showed significant cognitive improvement in adults with mild cognitive impairment at 16 weeks. Effect reversed after discontinuation, confirming direct causality. Mechanism: NGF (Nerve Growth Factor) stimulation.
View Study SourceAuthor: Linde K et al.
Disease: Depression
Treatment: St. John's Wort (Hypericum)
Journal: Cochrane Database of Systematic Reviews
Date: 2008-10-08
Meta-analysis of 29 trials (5,489 patients): St. John's Wort superior to placebo and similarly effective as standard antidepressants for mild-moderate depression, with significantly fewer side effects and discontinuations.
View Study SourceAuthor: Kunnumakkara AB et al.
Disease: Multiple Cancers
Treatment: Curcumin
Journal: Cancer Letters
Date: 2008-07-01
Curcumin inhibits NF-κB, induces apoptosis, suppresses angiogenesis, and blocks tumor invasion across 30+ cancer types in vitro and in vivo. No significant toxicity at therapeutic doses.
View Study SourceAuthor: Zhang Y et al.
Disease: Type 2 Diabetes
Treatment: Berberine
Journal: Metabolism
Date: 2008-05-01
Head-to-head RCT: Berberine matched Metformin in HbA1c reduction (2.0% vs 2.0%), fasting glucose, and postprandial glucose. Berberine also reduced triglycerides and LDL significantly more than Metformin with fewer GI side effects.
View Study SourceAuthor: Kirsch I et al.
Disease: Depression
Treatment: SSRIs (Reanalysis)
Journal: PLOS Medicine
Date: 2008-02-26
Reanalysis of all FDA-submitted SSRI trial data including unpublished trials: true drug-placebo difference is below clinical significance for all but severely depressed patients. SSRI effect is largely placebo. True NNT estimated at 16–30.
View Study SourceAuthor: Blumenthal JA et al.
Disease: Depression
Treatment: Aerobic Exercise
Journal: Psychosomatic Medicine
Date: 2007-09-01
Duke SMILE Trial follow-up: exercise equivalent to Sertraline for major depression at 16 weeks. Exercise group had significantly lower relapse rates at 10-month follow-up. No side effects, no cost after initial period.
View Study SourceAuthor: Padayatty SJ et al.
Disease: Cancer
Treatment: High-Dose IV Vitamin C
Journal: CMAJ
Date: 2006-03-28
NIH-confirmed pro-oxidant mechanism: at high plasma concentrations, Vitamin C generates hydrogen peroxide selectively toxic to cancer cells while sparing normal cells. Three documented cases of unexpected cancer remission.
View Study SourceAuthor: Morgan G, Ward R, Barton M
Disease: All Cancers
Treatment: Chemotherapy (Meta-Analysis)
Journal: Clinical Oncology
Date: 2004-12-01
Systematic analysis of all randomized trials in Australia and USA: chemotherapy contributes only 2.1% to 5-year survival across all adult cancers combined. Authors call for honest disclosure to patients about marginal benefit.
View Study SourceAuthor: Appel LJ et al.
Disease: Hypertension
Treatment: DASH Diet
Journal: New England Journal of Medicine
Date: 1997-04-17
DASH diet reduced systolic BP by 8–14 mmHg — equivalent to first-line antihypertensive drug therapy — with no medications, no side effects, and additional benefits for cholesterol and metabolic health.
View Study SourceAuthor: Esselstyn CB Jr
Disease: Cardiovascular Disease
Treatment: Whole-Food Plant-Based Diet
Journal: Journal of Family Practice
Date: 1995-08-01
12-year follow-up: zero cardiac events in fully compliant patients on whole-food plant-based diet. Documented angiographic reversal of coronary artery disease. Zero pharmaceutical intervention. Cardiology industry has no financial incentive to promote.
View Study Source